These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8340231)

  • 1. Molecular monitoring of the immunosuppressive effects of cyclosporine in renal transplant patients by using a quantitative polymerase chain reaction.
    Koutouby R; Zucker C; Zucker K; Burke G; Nery J; Roth D; Esquenazi V; Miller J
    Hum Immunol; 1993 Apr; 36(4):227-34. PubMed ID: 8340231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal induced IL-2 mRNA monitoring in renal transplant patients immunosuppressed with cyclosporine and in unmodified canine renal transplant rejection.
    Zucker C; Zucker K; Asthana D; Carreno M; Viciana AL; Ruiz P; Esquenazi V; Nery J; Burke G; Miller J
    Hum Immunol; 1996 Jan; 45(1):1-12. PubMed ID: 8655354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed cytokine mRNA expression kinetics after T-lymphocyte costimulation: a quantitative measure of the efficacy of cyclosporin A-based immunosuppression.
    Härtel C; Fricke L; Schumacher N; Kirchner H; Müller-Steinhardt M
    Clin Chem; 2002 Dec; 48(12):2225-31. PubMed ID: 12446480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic assessment of the in vivo cyclosporine effect on interleukin-2 production by lymphocytes in kidney transplant recipients.
    Yoshimura N; Kahan BD
    Transplantation; 1985 Dec; 40(6):661-6. PubMed ID: 3934806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacodynamic effect of sirolimus: individual variation of cytokine mRNA expression profiles in human whole blood samples.
    Müller-Steinhardt M; Wortmeier K; Fricke L; Ebel B; Härtel C
    Immunobiology; 2009; 214(1):17-26. PubMed ID: 19159823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of whole-blood T lymphocytes in individual patients to tacrolimus (FK 506): impact of interleukin-2 mRNA expression as surrogate measure of immunosuppressive effect.
    Härtel C; Schumacher N; Fricke L; Ebel B; Kirchner H; Müller-Steinhardt M
    Clin Chem; 2004 Jan; 50(1):141-51. PubMed ID: 14709642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrophobic extracts of a Chinese herb (CMX-13) exhibit potent immunosuppressive properties and prevent acute rejection in a highly histoincompatible model of rat lung transplantation.
    Zuo XJ; Okada Y; Toyoda M; Yap HK; Marchevsky A; Matloff JM; Jordan SC
    Transplantation; 2000 Oct; 70(7):1094-8. PubMed ID: 11045648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression of the renal endothelin system in renal transplant recipients on cyclosporine A based immunosuppression.
    Asberg A; Attramadal H; Midtvedt K; Sund S; Hartmann A; Berg KJ
    Transplantation; 1999 Apr; 67(7):1056-60. PubMed ID: 10221493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of interleukin-2 mRNA in whole blood as a parameter for monitoring cyclosporine pharmacodynamics.
    Kuzuya T; Kobayashi T; Katayama A; Nagasaka T; Miwa Y; Uchida K; Nakao A; Yamada K
    Biol Pharm Bull; 2009 Apr; 32(4):604-8. PubMed ID: 19336891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
    Huang WH; Yan Y; De Boer B; Bishop GA; House AK
    Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
    Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
    Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive and mitogen-stimulated cytokine mRNA expression by peripheral blood mononuclear cells from most autologous and allogeneic bone marrow transplant recipients is intact.
    Lum LG; Joshi ID; Smith MR; Ratanatharathorn V; Galoforo SC; Karanes C; Uberti JP; Sensenbrenner LL
    Bone Marrow Transplant; 1994 Feb; 13(2):187-95. PubMed ID: 8205088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of nuclear factor of activated T cells is independent of the number of peripheral lymphocytes in FTY720-treated patients.
    Sommerer C; Morath C; Giese T; Meuer S; Zeier M
    Transplant Proc; 2008 Jun; 40(5):1416-8. PubMed ID: 18589120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic association of interleukin-2, interleukin-4, interleukin-6, transforming growth factor-β, tumour necrosis factor-α and blood concentrations of calcineurin inhibitors in Turkish renal transplant patients.
    Seyhun Y; Ciftci HS; Kekik C; Karadeniz MS; Tefik T; Nane I; Turkmen A; Oguz FS; Aydin F
    Int J Immunogenet; 2015 Jun; 42(3):147-60. PubMed ID: 25817300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft cytokine mRNA activity in rat single lung transplants by reverse transcription-polymerase chain reaction: effect of cyclosporine.
    Francalancia NA; Wang SC; Thai NL; Aeba R; Simmons RL; Yousem SA; Hardesty RL; Griffith BP
    J Heart Lung Transplant; 1992; 11(6):1041-5. PubMed ID: 1457427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cyclosporin a sensitivity in vivo in pediatric renal transplant recipients compared with adults.
    Billing H; Sommerer C; Giese T; Zeier M; Meuer S; Czock D; Tönshoff B
    Ther Drug Monit; 2012 Oct; 34(5):554-60. PubMed ID: 22929409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients: a novel perspective toward individually optimized drug doses of cyclosporine A.
    Giese T; Zeier M; Schemmer P; Uhl W; Schoels M; Dengler T; Buechler M; Meuer S
    Transplantation; 2004 Feb; 77(3):339-44. PubMed ID: 14966405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid, comprehensive analysis of human cytokine mRNA and its application to the study of acute renal allograft rejection.
    Kirk AD; Bollinger RR; Finn OJ
    Hum Immunol; 1995 Jun; 43(2):113-28. PubMed ID: 7591871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunopharmacodynamic evaluation of cyclosporine-treated renal allograft recipients.
    Rogers AJ; Yoshimura N; Kerman RH; Kahan BD
    Transplantation; 1984 Dec; 38(6):657-64. PubMed ID: 6239413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.